Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration says that it recently approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as an …
FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recenlty approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.
FDA Approves Treatment for Wider Range of Patients with Heart Failure Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart …
FDA Approves Treatment for Chronic Kidney Disease Read More